Parvovirus vaccine (MedImmune)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameParvovirus vaccine (MedImmune)

Drug Alias NameRecombinant baculovirus-expressed B19 parvovirus virus-like particle vaccine - MedImmune/NHLBIRecombinant baculovirusexpressed B19 parvovirus VLP vaccine - MedImmune/NHLBIB19 parvovirus vaccineMEDI-491

ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsParvoviridae Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNational Heart, Lung And Blood Institute National Institute of Health, Islamabad

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesChiron National Institutes Of Health National Heart, Lung And Blood Institute +[4]

Active IndicationsN/A

Inactive IndicationsParvoviridae Infections

Other Information

ATC CodeN/A